Evidence map›Paper›PMID 27347292›Full record

ArticleThe Pan African medical journal2016

Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.

Kelias Phiri Msyamboza, Maurice M'bang'ombe, Hannah Hausi, Alexander Chijuwa, Veronica Nkukumila, Hudson Wenji Kubwalo, Sachin Desai, Lorenzo Pezzoli, Dominique Legros

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Kelias Phiri MsyambozaWorld Health Organization, Malawi Country Office, Lilongwe, Malawi; University of Malawi, College of Medicine, Blantyre, Malawi.
Maurice M'bang'ombeMinistry of Health, Epidemiology Unit, Lilongwe, Malawi.
Hannah HausiJohn Snow Institute.
Alexander ChijuwaMinistry of Health, Nsanje District Hospital, Nsanje, Malawi.
Veronica NkukumilaMinistry of Health, Nsanje District Hospital, Nsanje, Malawi.
Hudson Wenji KubwaloWorld Health Organization, Malawi Country Office, Lilongwe, Malawi.
Sachin DesaiInternational Vaccine Institute, Saul, South Korea.
Lorenzo PezzoliGlobal Task Force for Cholera Control, Geneva, Switzerland.
Dominique LegrosWorld Health Organization, Geneva, Switzerland.
Ministry of Health · MWJohn Snow (United States) · USWorld Health Organization · CHWorld Health Organization - Malawi · MW

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionDespite some improvement in provision of safe drinking water, proper sanitation and hygiene promotion, cholera still remains a major public health problem in Malawi with outbreaks occurring almost every year since 1998. In response to 2014/2015 cholera outbreak, ministry of health and partners made a decision to assess the feasibility and acceptability of conducting a mass oral cholera vaccine (OCV) as an additional public health measure. This paper highlights the burden of the 2014/15 cholera outbreak, successes and challenges of OCV campaign conducted in March and April 2015.

methodsThis was a documentation of the first OCV campaign conducted in Malawi. The campaign targeted over 160,000 people aged one year or more living in 19 camps of people internally displaced by floods and their surrounding communities in Nsanje district. It was a reactive campaign as additional measure to improved water, sanitation and hygiene in response to the laboratory confirmed cholera outbreak.

resultsDuring the first round of the OCV campaign conducted from 30 March to 4 April 2015, a total of 156,592 (97.6%) people out of 160,482 target population received OCV. During the second round (20 to 25 April 2015), a total of 137,629 (85.8%) people received OCV. Of these, 108,247 (67.6%) people received their second dose while 29,382 (18.3%) were their first dose. Of the 134,836 people with known gender and sex who received 1 or 2 doses, 54.4% were females and over half (55.4%) were children under the age of 15 years. Among 108,237 people who received 2 doses (fully immunized), 54.4% were females and 51.9% were children under 15 years of age. No severe adverse event following immunization was reported. The main reason for non-vaccination or failure to take the 2 doses was absence during the period of the campaign.

conclusionThis documentation has demonstrated that it was feasible, acceptable by the community to conduct a large-scale mass OCV campaign in Malawi within five weeks. Of 320,000 OCV doses received, Malawi managed to administer at least 294,221 (91.9%) of the doses. OCV could therefore be considered to be introduced as additional measure in cholera hot spot areas in Malawi.

Indexed as

Patient Acceptance of Health CareAdministration, OralAdolescentChildChild, PreschoolCholeraCholera VaccinesDisease OutbreaksFeasibility StudiesFemaleHumansInfantMalawiMaleMass VaccinationPublic HealthCholera VaccinesCholeraMalawioral cholera vaccinesub-Saharan Africa

Identifiers

PMID27347292
PMCPMC4907756
OpenAlexW2337611420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.